Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Novitapeptide Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Novitapeptide Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Novitapeptide Bio
Manufacturer of peptide-based materials intended for continuous and environmentally friendly synthesis applications. The company offers scalable production processes, green chemistry techniques, and modular synthesis capabilities, enabling pharmaceutical and biotechnology markets to access high-purity compounds with reduced environmental impact, improved manufacturing efficiency, and enhanced adaptability for diverse therapeutic and research needs.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Novitapeptide Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Novitapeptide Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Novitapeptide Bio in its N-PORT filings yet. We sweep new filings monthly.